Olanzapine Completed Phase 2 Trials for Chemotherapy-Induced Nausea and Vomiting (CINV) Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT02129478Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study